Dans ce numéro qui publie de bons articles de radioprotection médicale et environnementale, je voudrais aussi attirer votre attention sur l'article de M. Kerveillant : « The role of the public in the French nuclear sector: the case of the local information commissions for nuclear activities » et sur le commentaire éditorial associé de F. Jeffroy, expert en sciences humaines et sociales : l'implication des parties prenantes en radioprotection est une question essentielle.
Secondary cancer or second primary cancer?
In this issue, Radioprotection publishes an article from J.M. Cosset et al. entitled "Second cancers after radiotherapy: update and recommendations". This article makes a review of literature on this question of paramount importance in radiological protection. Indeed, the radiation therapist's wish is to cure the patient's cancer and not to contribute to the induction of a radioinduced secondary cancer, even with a frequency of secondary cancers attributable to radiotherapy of about 8% (12% in children). However, it is still impossible to determine with absolute certainty the origin of a second cancer: is it a secondary radiationinduced cancer or a second primary cancer? Predicting the occurrence of a second cancer is difficult, whereas anticipating the potential occurrence of such an event and possibly its prevention is essential.
Another question remains: can a patient who has developed a first cancer be predisposed to cancer in general, and therefore likely to develop a second cancer later? Considering that cell transformation to cancer results from a combination of successive DNA insults and the progressive acquisition of specific hallmarks of malignity, cancer prone patients should be protected against all genotoxic compounds and factors, including ionising radiation. The paper from J.M. Cosset et al. gives a clear vision on the issue of second cancers after radiotherapy and proposes recommendations to reduce the risk.
Thus, time has come to try to identify persons/patients who are cancer prone and more radiosusceptible to cancer. In addition, general radiation protection recommendations, in terms of justification and optimisation of exposure to ionising radiation, for patients at risk of cancer have yet to be proposed. Articles dealing with this problem are obviously welcome in Radioprotection.
In the current issue, among good articles in medical and environmental radiological protection, I would also like to draw your attention to the article from M. Kerveillant "The role of the public in the French nuclear sector: the case of the local information commissions for nuclear activities" together with an editorial comment from F. Jeffroy as an expert in human and social sciences: the empowerment of the stakeholders in radiological protection is a critical issue to be further addressed.
